AI-generated summary
The authors studied human lung adenocarcinoma cells (ASTC-a-1) exposed to high fluence low-power laser irradiation (HF-LPLI), a pro-apoptotic stimulus. They report that HF-LPLI increases survivin activity through a ROS/cdc25c/CDK1 signaling pathway, and that higher survivin activity reduced apoptosis while lower activity increased it. The authors conclude that survivin can mediate self-protection during HF-LPLI-induced tumor cell apoptosis. The study was conducted in cultured cells, so its findings may not apply directly to living tissue.
- Who or what was studied
- Human lung adenocarcinoma cells (ASTC-a-1) in culture
- Limits stated in the abstract
- The study used cultured tumor cells only, and the abstract reports no in vivo or human data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Reactive oxygen species, Fluence, Laser, Photodynamic therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.